Onconova Therapeutics, Inc.
Onconova Therapeutics, Inc. (ONTX) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 215 transactions totaling $55.0M, demonstrating a bullish sentiment with $49.0M in net insider flow. The most recent transaction on Mar 14, 2024 involved a transaction of 8,727 shares valued at $7.9K.
ONTX Insider Activity Summary
Who Is Buying ONTX Stock?
No significant insider buying has been recorded for ONTX in the recent period.
Who Is Selling ONTX Stock?
No significant insider selling has been recorded for ONTX in the recent period.
Is Onconova Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ONTX is bullish with an Insider Alignment Score of 94/100 and a net flow of $49.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ONTX Frequently Asked Questions
Understanding ONTX Insider Activity
Insider trading at Onconova Therapeutics, Inc. (ONTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading ONTX stock, having executed 215 transactions in the past 90 days. The most active insider is Michael B. Hoffman (Executive), who has made 30 transactions totaling $19.6M.
Related Tools
Track Onconova Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ONTX file new Form 4 transactions